indazoles has been researched along with Cognition Disorders in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, Y; Feng, D; Gao, G; Li, Y; Liu, D; Liu, H; Qin, H; Wang, J; Wen, H; Yin, Z; Zhao, D | 1 |
Garibaldi, G; Keefe, RS; Lowe, DA; Murray, S; Porter, R; Santarelli, L; Umbricht, D | 1 |
Chopra, K; Kuhad, A; Misra, S | 1 |
Chen, J; Huang, Y; Jiang, H; Lu, Y; Yan, J | 1 |
Comery, TA; Di, L; Kerns, EH; Kowal, DM; Liu, KG; Lo, JR; Robichaud, AJ; Schechter, LE; Smith, DL; Zhang, GM; Zhang, JY | 2 |
1 trial(s) available for indazoles and Cognition Disorders
Article | Year |
---|---|
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Bridged Bicyclo Compounds; Cognition Disorders; Double-Blind Method; Female; Humans; Indazoles; Male; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2014 |
5 other study(ies) available for indazoles and Cognition Disorders
Article | Year |
---|---|
Protective effect of HIF-1α against hippocampal apoptosis and cognitive dysfunction in an experimental rat model of subarachnoid hemorrhage.
Topics: Animals; Apoptosis; Blood Pressure; Caspase 3; Cognition Disorders; Disease Models, Animal; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Excitatory Amino Acid Transporter 2; Hippocampus; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Male; Maze Learning; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Reaction Time; Subarachnoid Hemorrhage; Vascular Endothelial Growth Factor A | 2013 |
Neurobiological effect of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in experimental paradigm of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognition Disorders; Enzyme Inhibitors; Humans; Indazoles; Male; Maze Learning; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Rats; Streptozocin | 2013 |
Repeated administration of ketamine can induce hippocampal neurodegeneration and long-term cognitive impairment via the ROS/HIF-1α pathway in developing rats.
Topics: Analgesics; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Calcium Channel Blockers; Carnitine; Cells, Cultured; Cognition Disorders; Female; Hippocampus; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Ketamine; Male; Maze Learning; Neurodegenerative Diseases; Neurons; Nimodipine; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Vitamin B Complex | 2014 |
1-Sulfonylindazoles as potent and selective 5-HT6 ligands.
Topics: Administration, Oral; Animals; Biological Availability; Central Nervous System Diseases; Cognition Disorders; Drug Design; Humans; Indazoles; Inhibitory Concentration 50; Kinetics; Ligands; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin | 2009 |
Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
Topics: Cognition Disorders; Dementia; Humans; Indazoles; Ligands; Piperidines; Receptors, Serotonin; Serotonin Antagonists; Sulfinic Acids | 2009 |